Inventor · disambiguated record
Fred Lawrence Ciske
Also filed as: CISKE FRED L · CISKE FRED LAWRENCE
20 granted patents·10 pending applications·83 citations·filing 1997–2022
93Inventor score
Files withCAYMAN CHEMICAL CO INC17UPJOHN CO5BARRETT STEPHEN DOUGLAS1ENDRES GREGORY W1HOECHST MARION ROUSSEL INC1
Top patents by PatentIndex Score
30 records- 0188US6559145B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted May 6, 2003·29 cites·25 claims
- 0286US9487478B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2015·Granted Nov 8, 2016·4 cites·21 claims
- 0385US9180116B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2013·Granted Nov 10, 2015·6 cites·20 claims
- 0485US6624159B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2001·Granted Sep 23, 2003·26 cites·46 claims
- 0582US9440919B2Difluorolactam compositions for EP4-mediated osteo related diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2013·Granted Sep 13, 2016·4 cites·23 claims
- 0680US9701630B2Difluorolactam compositions for EP4-mediated osteo related diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2016·Granted Jul 11, 2017·2 cites·20 claims
- 0777US11884624B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2021·Granted Jan 30, 2024·0 cites·3 claims
- 0873US11066361B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2020·Granted Jul 20, 2021·0 cites·3 claims
- 0972US8536185B2Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseasesENDRES GREGORY W·Filed 2009·Granted Sep 17, 2013·2 cites·57 claims
- 1069US6365612B2Benzosultam oxazolidinone antibacterial agentsUPJOHN CO·Filed 2001·Granted Apr 2, 2002·4 cites·20 claims
- 1167US10556862B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2018·Granted Feb 11, 2020·0 cites·4 claims
- 1262US9120820B2Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteinsBARRETT STEPHEN DOUGLAS·Filed 2012·Granted Sep 1, 2015·1 cites·7 claims
- 1359US2017066751A1Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2016·Application pending·0 cites
- 1458US9126973B2Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseasesCAYMAN CHEMICAL CO INC·Filed 2014·Granted Sep 8, 2015·0 cites·51 claims
- 1558US6831081B24-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agentsPHARMACIA & UPJOHN·Filed 2003·Granted Dec 14, 2004·1 cites·55 claims
- 1658US2024174631A1Compounds, compositions, and methods for modulating fgf activityRECOVERY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1755US2019144435A1Difluorolactam compositions for ep4-mediated osteo related diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2019·Application pending·0 cites
- 1853US2017260173A1Difluorolactam compositions for ep4-mediated osteo related diseases and condtionsCAYMAN CHEMICAL CO INC·Filed 2017·Application pending·0 cites
- 1953US2013079375A1Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseasesCAYMAN CHEMICAL CO INC·Filed 2012·Application pending·0 cites
- 2052US6903097B2Heterocycle carboxamides as antiviral agentsUPJOHN CO·Filed 2002·Granted Jun 7, 2005·0 cites·27 claims
- 2151US2004142928A1Heterocycle carboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 2249US10729810B2Methods, systems, and compositions for promoting bone growthCAYMAN CHEMICAL CO INC·Filed 2014·Granted Aug 4, 2020·0 cites·16 claims
- 2349US6004959AAlkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitorsHOECHST MARION ROUSSEL INC·Filed 1997·Granted Dec 21, 1999·4 cites·26 claims
- 2448US2004029879A1Heterocycle carboxamides as antiviral agentsFiled 2003·Application pending·0 cites
- 2547US9676712B2Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2014·Granted Jun 13, 2017·0 cites·24 claims
- 2646US2015322107A1Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteinsCAYMAN CHEMICAL CO INC·Filed 2015·Application pending·0 cites
- 2746US2015323542A1Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteinsCAYMAN CHEMICAL CO INC·Filed 2015·Application pending·0 cites
- 2843US2004116464A1Aryl-ethanolamine derivatives as antiviral agentsFiled 2003·Application pending·0 cites
- 2942US9688627B2Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2014·Granted Jun 27, 2017·0 cites·24 claims
- 3041US6825225B2Bicyclic isoxazolinones as antibacterial agentsUPJOHN CO·Filed 2001·Granted Nov 30, 2004·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Fred Lawrence Ciske files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →